0

539428

TEJNAKSH

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Tejnaksh Healthcare Limited Share Price Today

Investment Returns

Over 1 Month 3.86% Over 3 Months 7.79% Over 6 Months -5.53% Over 1 Year -31.31%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Tejnaksh Healthcare Limited fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 31.80
  • P/E Ratio (TTM) 21.56
  • Beta 0.56
  • Book Value / share 13.19
  • Return on equity 10.87%
  • EPS (TTM) 0.68
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.50
info icon alternate text

Tejnaksh Healthcare Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 1.77
Operating Expense 1.31
Net Profit 0.50
Net Profit Margin (%) 28.24
Earnings Per Share (EPS) 0.39
EBITDA 0.96
Effective Tax Rate (%) 17.74
Particulars DEC 2025 (Values in Cr)
Revenue 1.69
Operating Expense 1.46
Net Profit 0.23
Net Profit Margin (%) 13.60
Earnings Per Share (EPS) 0.11
EBITDA 0.66
Effective Tax Rate (%) 23.33
Particulars SEP 2025 (Values in Cr)
Revenue 1.94
Operating Expense 1.59
Net Profit 0.31
Net Profit Margin (%) 15.97
Earnings Per Share (EPS) 0.15
EBITDA 0.79
Effective Tax Rate (%) 26.19
Particulars JUN 2025 (Values in Cr)
Revenue 1.78
Operating Expense 1.41
Net Profit 0.34
Net Profit Margin (%) 19.10
Earnings Per Share (EPS) 0.17
EBITDA 0.82
Effective Tax Rate (%) 24.44
Particulars MAR 2025 (Values in Cr)
Revenue 2.40
Operating Expense 1.43
Net Profit 0.75
Net Profit Margin (%) 31.25
Earnings Per Share (EPS) 0.37
EBITDA 1.23
Effective Tax Rate (%) 26.92
Particulars MAR 2026 (Values in Cr)
Revenue 7.17
Operating Expense 5.76
Net Profit 1.38
Net Profit Margin (%) 19.24
Earnings Per Share (EPS) 0.68
EBITDA 3.23
Effective Tax Rate (%) 22.90
Particulars MAR 2025 (Values in Cr)
Revenue 8.80
Operating Expense 5.49
Net Profit 2.62
Net Profit Margin (%) 29.77
Earnings Per Share (EPS) 1.29
EBITDA 4.83
Effective Tax Rate (%) 28.41
Particulars MAR 2024 (Values in Cr)
Revenue 8.22
Operating Expense 6.07
Net Profit 1.81
Net Profit Margin (%) 22.01
Earnings Per Share (EPS) 0.89
EBITDA 3.92
Effective Tax Rate (%) 25.51
Particulars MAR 2023 (Values in Cr)
Revenue 7.34
Operating Expense 5.60
Net Profit 1.38
Net Profit Margin (%) 18.80
Earnings Per Share (EPS) 0.68
EBITDA 3.36
Effective Tax Rate (%) 29.59
Particulars MAR 2022 (Values in Cr)
Revenue 8.12
Operating Expense 4.88
Net Profit 2.52
Net Profit Margin (%) 31.03
Earnings Per Share (EPS) 2.48
EBITDA 4.43
Effective Tax Rate (%) 25.22
Particulars MAR 2025 (Values in Cr)
Book Value / Share 12.76
ROE % 9.01
ROCE % 12.77
Total Debt to Total Equity 0.12
EBITDA Margin 34.88
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.60
ROE % 7.76
ROCE % 10.64
Total Debt to Total Equity 0.25
EBITDA Margin 32.35
Particulars MAR 2023 (Values in Cr)
Book Value / Share 21.43
ROE % 8.56
ROCE % 11.24
Total Debt to Total Equity 0.32
EBITDA Margin 34.19
Particulars MAR 2022 (Values in Cr)
Book Value / Share 19.75
ROE % 15.03
ROCE % 17.08
Total Debt to Total Equity 0.32
EBITDA Margin 38.72
Particulars MAR 2021 (Values in Cr)
Book Value / Share 17.05
ROE % 12.71
ROCE % 14.10
Total Debt to Total Equity 0.37
EBITDA Margin 32.19
Particulars MAR 2025 (Values in Cr)
Book Value / Share 12.51
ROE % 10.87
ROCE % 14.64
Total Debt to Total Equity 0.12
EBITDA Margin 55.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.21
ROE % 8.28
ROCE % 11.12
Total Debt to Total Equity 0.26
EBITDA Margin 47.81
Particulars MAR 2023 (Values in Cr)
Book Value / Share 20.62
ROE % 6.81
ROCE % 9.41
Total Debt to Total Equity 0.33
EBITDA Margin 45.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 19.25
ROE % 13.77
ROCE % 15.63
Total Debt to Total Equity 0.33
EBITDA Margin 54.68
Particulars MAR 2021 (Values in Cr)
Book Value / Share 16.76
ROE % 12.48
ROCE % 13.82
Total Debt to Total Equity 0.38
EBITDA Margin 43.69
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.79
Total Assets 30.30
Total Liabilities 30.30
Total Equity 26.45
Share Outstanding 2
Price to Book Ratio 1.68
Return on Assets (%) 7.68
Return on Capital (%) 8.59
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.25
Total Assets 31.35
Total Liabilities 31.35
Total Equity 24.20
Share Outstanding 2
Price to Book Ratio 2.07
Return on Assets (%) 5.66
Return on Capital (%) 6.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.13
Total Assets 31.22
Total Liabilities 31.22
Total Equity 22.41
Share Outstanding 1
Price to Book Ratio 3.34
Return on Assets (%) 5.38
Return on Capital (%) 5.95
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.00
Total Assets 29.60
Total Liabilities 29.60
Total Equity 20.59
Share Outstanding 1
Price to Book Ratio 8.75
Return on Assets (%) 9.19
Return on Capital (%) 10.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.23
Total Assets 24.57
Total Liabilities 24.57
Total Equity 17.76
Share Outstanding 1
Price to Book Ratio 4.34
Return on Assets (%) 8.35
Return on Capital (%) 9.35
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.64
Total Assets 29.00
Total Liabilities 29.00
Total Equity 25.40
Share Outstanding 2
Price to Book Ratio 1.68
Return on Assets (%) 9.03
Return on Capital (%) 10.07
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.94
Total Assets 30.11
Total Liabilities 30.11
Total Equity 22.77
Share Outstanding 2
Price to Book Ratio 2.07
Return on Assets (%) 6.01
Return on Capital (%) 6.74
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.47
Total Assets 29.80
Total Liabilities 29.80
Total Equity 20.94
Share Outstanding 1
Price to Book Ratio 3.34
Return on Assets (%) 4.62
Return on Capital (%) 5.13
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.43
Total Assets 28.67
Total Liabilities 28.67
Total Equity 19.55
Share Outstanding 1
Price to Book Ratio 8.75
Return on Assets (%) 8.78
Return on Capital (%) 9.73
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.56
Total Assets 23.87
Total Liabilities 23.87
Total Equity 17.02
Share Outstanding 1
Price to Book Ratio 4.34
Return on Assets (%) 8.39
Return on Capital (%) 9.43
Particulars MAR 2025 (Values in Cr)
Net Income 3.19
Cash from Operations 0.85
Cash from Investing 3.52
Cash from Financing -3.86
Net change in Cash 0.03
Free Cash Flow 1.10
Particulars MAR 2024 (Values in Cr)
Net Income 2.37
Cash from Operations 4.34
Cash from Investing -1.01
Cash from Financing -2.26
Net change in Cash 0.72
Free Cash Flow 5.04
Particulars MAR 2023 (Values in Cr)
Net Income 2.51
Cash from Operations 1.70
Cash from Investing -1.40
Cash from Financing -1.19
Net change in Cash -0.47
Free Cash Flow 2.52
Particulars MAR 2022 (Values in Cr)
Net Income 3.76
Cash from Operations 8.96
Cash from Investing -10.58
Cash from Financing 1.61
Net change in Cash 0.23
Free Cash Flow 18.04
Particulars MAR 2021 (Values in Cr)
Net Income 2.66
Cash from Operations 0.47
Cash from Investing 1.55
Cash from Financing -2.80
Net change in Cash -0.06
Free Cash Flow 0.91
Particulars MAR 2025 (Values in Cr)
Net Income 3.66
Cash from Operations 0.97
Cash from Investing 3.57
Cash from Financing -3.86
Net change in Cash 0.19
Free Cash Flow 1.16
Particulars MAR 2024 (Values in Cr)
Net Income 2.43
Cash from Operations 4.47
Cash from Investing -1.07
Cash from Financing -2.31
Net change in Cash 0.75
Free Cash Flow 4.90
Particulars MAR 2023 (Values in Cr)
Net Income 1.96
Cash from Operations 1.51
Cash from Investing -0.98
Cash from Financing -1.17
Net change in Cash -0.25
Free Cash Flow 2.20
Particulars MAR 2022 (Values in Cr)
Net Income 3.37
Cash from Operations 8.88
Cash from Investing -10.39
Cash from Financing 1.61
Net change in Cash 0.34
Free Cash Flow 17.74
Particulars MAR 2021 (Values in Cr)
Net Income 2.59
Cash from Operations 0.34
Cash from Investing 1.55
Cash from Financing -2.86
Net change in Cash -0.46
Free Cash Flow 0.78
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8496.80 62.45 12.89 122170.95 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 52.22 23.63 2.85 97.87 40.75 76.00
SHREE PACETRONIX LTD. 134.30 16.03 2.82 50.36 66.10 283.15
TRANSGENE BIOTEK LTD. 3.16 0.00 2.85 23.94 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8496.80 81.38 12.26 122170.95 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.25 0.00 -9.55 29.32 30.30 57.48
KOVAI MEDICAL CENTER & HO 5834.80 26.11 4.83 6383.27 5010.00 6725.00

Tejnaksh Healthcare Limited shareholding pattern

Holding
26.16%
73.83%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Tejnaksh Healthcare Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
15.63 6.61 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 14.70
  • 26 Days 14.70
  • 10 Days 14.60
  • 50 Days 14.70
  • 12 Days 14.60
  • 100 Days 14.90
  • 20 Days 14.70
  • 200 Days 16.00
15.20 PIVOT
First Support 14.41 First Resistance 15.72 Second Support 13.89 Second Resistance 16.51 Third Support 13.10 Third Resistance 17.03
RSI 47.92 ADX 32.11 MACD -0.08 Williams % R -54.68 Commodity Channel Index (CCI) -0.75
Date 2026-06-19 Week 8936.00 Same Day 23035.00 Month 5354.00
1 Year 0.56 3 Year 0.61
Over 1 Month
3.86% down
Over 1 Year
-31.31% down
Over 3 Months
7.79% down
Over 3 Years
-23.92% down
Over 6 Months
-5.53% down
Over 5 Years
-14.85% down

Tejnaksh Healthcare Limited Corporate Actions

Ex-Date Ex-Bonus Ratio
28 Apr 2018 26 Apr 2018 36:10
09 Mar 2017 08 Mar 2017 1:1
Ex-Date Old FV NEW FV Record Date
19 Jul 2023 10.0 5.0 19 Jul 2023

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Tejnaksh Healthcare Ltd?

Answer Field

Tejnaksh Healthcare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 15.63 as on Jun 25 2026 09:31 AM.

What is the Market Cap of Tejnaksh Healthcare Ltd Share?

Answer Field

The market cap of Tejnaksh Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 31.80 as on Jun 25 2026 09:31 AM.

What is the 52 Week High and Low of Tejnaksh Healthcare Ltd?

Answer Field

The 52 Week High and Low of Tejnaksh Healthcare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 21.79 and ₹ 10.65.

What is 1 year return for Tejnaksh Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been -31.17%.

What is the P/E Ratio of Tejnaksh Healthcare Ltd Share?

Answer Field

As on Jun 25 2026 09:31 AM the price-to-earnings (PE) ratio for Tejnaksh Healthcare Ltd share is 21.56.

What is the PB ratio of Tejnaksh Healthcare Ltd Share?

Answer Field

As on Jun 25 2026 09:31 AM, the price-to-book (PB) ratio for Tejnaksh Healthcare Ltd share is 13.19.

How to Buy Tejnaksh Healthcare Ltd Share?

Answer Field

You can trade in Tejnaksh Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Tejnaksh Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Tejnaksh Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Tejnaksh Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|